Cutaneous adverse effects of COVID- 19 vaccines: A cross-sectional study among AstraZeneca and Sinovac vaccine recipients at UERMMMCI
- Author:
Jose Alberto M. Lim
1
;
Carmela Franchesca L. Miranda
1
;
Cathrine Ilene B. Ang
1
;
Juanita Carmela Co- Buenviaje
1
;
Lian C. Jamisola
1
;
Camille B. Angeles
1
Author Information
- Publication Type:Journal Article
- Keywords: Drug reaction,
- MeSH: Vaccines; COVID-19; Pandemics
- From: Health Sciences Journal 2024;13(1):26-30
- CountryPhilippines
- Language:English
-
Abstract:
Introduction:COVID-19 has emerged as a global problem with vaccines being established as one of the
best tools in its control. Of particular interest in dermatology are risks and manifestations of cutaneous
reactions from such countermeasures, with strides made in documenting and associating skin reactions
with vaccines against COVID-19. This study aimed to determine the incidence of cutaneous adverse
reactions in recipients of recombinant ChAdOx1-S and inactivated SARS-COV-2 vaccines among healthcare
personnel and employees of UERMMMCI.
Methods:A cross-sectional study was done were respondents, chosen through randomized stratified cluster sampling, were given a questionnaire to elicit cutaneous adverse effects associated with COVID-19 vaccines.
Results:There were198 respondents, of which 29.3% were male and 70.7% were female, with a mean age of 26.07 years. Of these respondents, 72 (36.36%) received recombinant ChAdOx1-S and 126 (63.64%) received inactivated SARS-COV-2 vaccine. For the first dose, cutaneous reactions developed in 6 (8.33%) recipients of recombinant ChAdOx1-S, and 2 (1.59%) recipients of inactivated SARS-COV-2. For the second dose, no reactions followed vaccination with recombinant ChAdOx1-S while 4 (3.17%) reactions developed after inactivated SARS-COV-2 vaccination. Lesions were mostly confined to the injection site presenting with erythema for both vaccine types. One urticarial, widespread reaction was associated with a second dose of inactivated SARS-COV-2 vaccine.
Conclusions:Adverse reactions to COVID-19 vaccinations have been documented which may be attributed to respective excipients rather than vaccine antigens. Due to the rare occurrence of severe anaphylactic reactions, vaccine use is recommended as they confer protection even to those with prior infections. Documented reactions in this study were observed to be mild and self- limiting similar to larger studies. - Full text:2024062820121434961Cutaneous.pdf
